Skip to main navigation
Skip to search
Skip to main content
University of Hertfordshire (Research Profiles) Home
Search content at University of Hertfordshire (Research Profiles)
Home
Profiles
Research output
Projects
Research units
C-Abl Inhibition; A Novel Therapeutic Target for Parkinson's Disease
Abdelrahman Ibrahim Abushouk
, Ahmed Negida
,
Rasha Abdelsalam Elshenawy
, Hossam Zein
, Ali M. Hammad
, Ahmed Menshawy
, Wael M.Y. Mohamed
Centre for Health Services and Clinical Research
Research output
:
Contribution to journal
›
Article
›
peer-review
36
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'C-Abl Inhibition; A Novel Therapeutic Target for Parkinson's Disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Novel Therapeutic Targets
100%
Parkinson's Disease
100%
C-Abl
100%
Neuroprotective Effect
25%
Neurodegeneration
25%
First-in-human Trials
25%
Clinical Trials
12%
Current Treatment
12%
Lack of Data
12%
Disease-modifying Strategies
12%
Abelson Kinase
12%
Disease Pathogenesis
12%
Human Trials
12%
Dopaminergic Neurons
12%
Lewy Bodies
12%
Drug Target
12%
Parkin
12%
Preclinical Experiment
12%
Toxic Elements
12%
α-synuclein Aggregation
12%
Neuroprotection
12%
Impaired Autophagy
12%
Tyrosine Kinase Enzyme
12%
Movement Disorders
12%
Dopaminergic Neuronal Death
12%
Neuroprotective Agents
12%
Neuroscience
Parkinson's Disease
100%
Neuroprotective Agent
37%
Neurodegeneration
25%
Lewy Body
12%
Alpha-Synuclein
12%
Neuroprotection
12%
Stereotypic Movement Disorder
12%
Autophagy
12%
Neuronal Cell Death
12%
Parkin
12%
Dopaminergic
12%
Abelson Kinase
12%
Dopaminergic Neuron
12%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
100%
Neuroprotective Agent
37%
Dopamine Receptor Stimulating Agent
25%
Nerve Degeneration
25%
Neuroprotection
12%
Motor Dysfunction
12%
Clinical Trial
12%
Alpha Synuclein
12%
Disease
12%
Parkin
12%
Abelson Kinase
12%
Lewy Body
12%